Conference abstractPublished 27 Jul 2017
F18 PSMA scanning. A disruptive change in prostate cancer care and management. Experience from Australasia
Pacific Radiology Ltd, New Zealand
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The need for a distributable F18 based PSMA agent in New Zealand. I will present the distribution routes for Melbourne and Wellington based cyclotrons and pharmacy. I will review the first ~200 cases in this retrospective cohort from referrals by Urologists and Radiation Oncology with relation to disease case mix, and correlation with PSA and other imaging including 3T MRI of primary disease and 18F PET/CT bone scanning and body CT of disseminated disease. A subset of comparison of PSMA imaging against multiparametric mainly 3T MRI will be included. Representative slides will highlight points of interest.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNephrology & Urology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Trevor Fitzjohn”